Sinopharm
1099.HK
#2138
Rank
A$11.61 B
Marketcap
$3.72
Share price
1.72%
Change (1 day)
-8.23%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): A$3.61 Billion

According to Sinopharm's latest financial reports the company's current earnings are A$80.09 Billion. In 2024 the company made an earning of A$3.53 Billion a decrease over its 2023 earnings that were of A$4.90 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2024A$3.53 B-27.86%
2023 A$4.90 B-0.73%
2022 A$4.94 B-1.72%
2021A$5.02 B11.7%
2020A$4.50 B18.44%
2019A$3.79 B10.85%
2018A$3.42 B3.05%
2017A$3.32 B36.48%
2016A$2.43 B7.11%
2015A$2.27 B12.38%
2014A$2.02 B25.05%
2013A$1.61 B22.54%
2012A$1.32 B35.43%
2011A$0.97 B52.24%
2010A$0.64 B30.99%
2009A$0.48 B60.59%
2008A$0.30 B48.29%
2007A$0.20 B123.29%
2006A$92.01 M